Physician profile
Irisa Devine
NPI 1437384583
$328.82
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6.40 · 2020: $4.41 · 2021: $14.76 · 2022: $51.63 · 2023: $139 · 2024: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174 · Education: $77.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.32 |
| Education | $77.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $147.91 | 2022-2024 | Spinraza |
| Regeneron Healthcare Solutions, INC. | $49.60 | 2023-2024 | Dupixent |
| Neurelis, INC. | $33.20 | 2021-2024 | Valtoco |
| Dexcom, INC. | $22.91 | 2024 | Dexcom G6 Transmitter |
| Ns Pharma, INC. | $22.60 | 2023 | Viltepso |
| Livanova USA, INC. | $21.73 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Novartis Gene Therapies, INC. (Fka Avexis, INC.) | $20.06 | 2022 | |
| Travere Therapeutics, INC. | $10.81 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irisa Devine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.